BMEDvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with BMED, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/17/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED ETF 2 | +7.90%– | +4.20%– | +1.48%– | +23.30%– | +23.27%– | +4.16%– |
| Flows | BMED ETF 2 | -– | -– | +$4M– | +$6M– | +$4M– | +$5M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED ETF 2 | +17.48%– | +15.99%– | +16.00%– | +17.71%– |
| Max drawdown | BMED ETF 2 | -7.61%– | -14.71%– | -19.76%– | -33.96%– |
| Max drawdown duration | BMED ETF 2 | 65d– | 176d– | 237d– | 1586d– |
Trading data
BMED | ETF 2 | |
Last sale 7/17/2026 at 1:30 PM | $30.65 | – |
| Previous close 07/16/2026 | $30.80 | – |
| Consolidated volume 07/16/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/17/2026 at 1:30 PM
Live
Closed
BMED | ETF 2 | |
|---|---|---|
| Last price | $30.65 | – |
| 1D performance | -0.49% | – |
| AuM | $11.03 M | – |
| E/R | 0.77% | – |
Characteristics
BMED | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | iShares | – |
| Benchmark | - | – |
| N° of holdings | 51 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 29, 2020 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
BMED
USA
83.2%
Other
16.8%
ETF 2
Sectors
BMED
Healthcare
94.88%
Other
5.12%
ETF 2
Advertisement
Diversification
BMED
Total weight of top 15 holdings out of 15
57.26%
ETF 2
–
Top 15 holdings
Data as of May 31, 2026
BMED
Gilead Sciences, Inc.
5.42%
Merck & Co., Inc.
5.17%
Johnson & Johnson
5.15%
Edwards Lifesciences Corp.
4.79%
BlackRock Cash Funds - Treasury
4.74%
Waters Corp.
3.84%
Biogen, Inc.
3.67%
Bruker Corp.
3.64%
Amgen, Inc.
3.41%
WuXi Biologics (Cayman), Inc.
3.13%
Charles River Laboratories International, Inc.
3.12%
Vertex Pharmaceuticals, Inc.
2.99%
Mettler-Toledo International, Inc.
2.80%
Danaher Corp.
2.77%
Moderna, Inc.
2.65%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
